Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ulrich Bernd Keller (Zonera Hassan, Ulrich Keller)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 27

Top Venues

Cancers

Leukemia

Blood advances

International journal of molecular sciences

Charité Universitätsmedizin Berlin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charité Universitätsmedizin Berlin Nov 1o 2018

Germany

Professor and Medical director :: Hematology, Oncology, Tumor Immunology

Publications

Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Bernd Keller, Sebastian Ochsenreither
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International journal of molecular sciences 24 (3) (2023)
Le Zhang, Matthias Wirth, Upayan Patra, Jacob Stroh, Konstandina Isaakidis, Leonie Rieger, Susanne Kossatz, Maja Milanovic, Chuanbing Zang, Uta Demel, Jan Keiten-Schmitz, Kristina Wagner, Katja Steiger, Roland Rad, Florian Bassermann, Stefan Müller, Ulrich Bernd Keller, Markus Schick
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response. EMBO molecular medicine (2023)
Michael Fuchs, Anne Sophie Jacob, Helen Kaul, Carsten Kobe, Georg Kuhnert, Thomas Pabst, Richard Greil, Paul J Bröckelmann, Max S Topp, Marianne Just, Bernd Hertenstein, Martin Soekler, Martin Vogelhuber, Josée M Zijlstra, Ulrich Bernd Keller, Stefan W Krause, Ulrich Dührsen, Julia Meissner, Andreas Viardot, Hans-Theodor Eich, Christian Baues, Volker Diehl, Andreas Rosenwald, Ina Buehnen, Bastian von Tresckow, Markus Dietlein, Peter Borchmann, Andreas Engert, Dennis A Eichenauer
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia (2023)
Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Bernd Keller, Sebastian Ochsenreither
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International journal of molecular sciences 24 (3) (2023)
Paul Schossig, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Bernd Keller, Sebastian Ochsenreither
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International journal of molecular sciences 24 (3) (2023)
Guus J J E Heynen, Francis Baumgartner, Michael Heider, Upayan Patra, Maximilian Holz, Jan Braune, Melanie Kaiser, Isabell Schäffer, Stefanos A Bamopoulos, Evelyn Ramberger, Arunima Murgai, Yuen Lam Dora Ng, Uta Margareta Demel, Dominik Laue, Sven Liebig, Josefine Krüger, Martin Janz, Axel Nogai, Markus Schick, Philipp Mertins, Stefan Müller, Florian Bassermann, Jan Krönke, Ulrich Bernd Keller, Matthias Wirth
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma. Blood advances (2022)
Andrés José Maria Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Claudia Celico, Monica Falautano, Alessandro Nonis, Paul La Rosée, Mascia Binder, Alberto Fabbri, Fiorella Ilariucci, Mauro Krampera, Alexander Roth, Claire Hemmaway, Peter W Johnson, Kim M Linton, Tobias Pukrop, Jettes Sønderskov Gørløv, Monica Balzarotti, Georg Hess, Ulrich Bernd Keller, Stephan Stilgenbauer, Jens Peter Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Manuela Zanni, Stefan W Krause, Hans J Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Juergen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, null null
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia 36 (7) (2022)
Carmen Paulmann, Ria Spallek, Oleksandra Karpiuk, Michael Heider, Isabell Schäffer, Jana Zecha, Susan Klaeger, Michaela Walzik, Rupert Öllinger, Thomas Engleitner, Matthias Wirth, Ulrich Bernd Keller, Jan Krönke, Martina Rudelius, Susanne Kossatz, Roland Rad, Bernhard Kuster, Florian Bassermann
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. The EMBO journal 41 (20) (2022)
Corinna Grunert, Gerald Willimksy, Caroline Anna Peuker, Simone Rhein, Leo Hansmann, Thomas Blankenstein, Eric Blanc, Dieter Beule, Ulrich Bernd Keller, Antonio Pezzutto, Antonia Busse
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires. Cancers 14 (7) (2022)
Markus Schick, Le Zhang, Sabine Maurer, Hans Carlo Maurer, Konstandina Isaakaidis, Lara Schneider, Upayan Patra, Kathrin Schunck, Elena Rohleder, Julia Hofstetter, Apoorva Baluapuri, Anna Katharina Scherger, Julia Slotta-Huspenina, Franziska Hettler, Julia Weber, Thomas Engleitner, Roman Maresch, Jolanta Slawska, Richard Ian Lewis, Rouzanna Istvanffy, Stefan Habringer, Katja Steiger, Armin Baiker, Robert A J Oostendorp, Christoph Cornelius Miething, Hans-Peter Lenhof, Florian Bassermann, Bjoern Chapuy, Matthias Wirth, Elmar Wolf, Roland Rad, Stefan Müller, Ulrich Bernd Keller
Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma. Nature communications 13 (1) (2022)
Özcan Çınar, Bernadette Brzezicha, Corinna Grunert, Peter Michael Kloetzel, Christin Beier, Caroline Anna Peuker, Ulrich Bernd Keller, Antonio Pezzutto, Antonia Busse
High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies. Journal for immunotherapy of cancer 9 (7) (2022)
Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Bernd Keller, Lars Bullinger, Jan Krönke
Relapse of NPM1 -Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation. Case reports in hematology 2022 (2022)
Yuen Lam Dora Ng, Evelyn Ramberger, Stephan R Bohl, Anna Dolnik, Christian Steinebach, Theresia Conrad, Sina Müller, Oliver Popp, Miriam Kull, Mohamed Haji, Michael Gütschow, Hartmut Döhner, Wolfgang Walther, Ulrich Bernd Keller, Lars Bullinger, Philipp Mertins, Jan Krönke
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma. Nature communications 13 (1) (2022)
Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T den Dekker, Rutger W W Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H Krämer, Markus Schick, Elmar Wolf, Wilfred F J Van IJcken, Irene Esposito, Ulrich Bernd Keller, Günter Schneider, Matthias Wirth
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (9) (2022)
Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Bernd Keller, Lars Bullinger, Jan Krönke
Relapse of NPM1 -Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation. Case reports in hematology 2022 (2022)
Julia Pohl, Raluca-Ileana Mincu, Simone M Mrotzek, Reza Wakili, Amir Abbas Mahabadi, Sophia K Potthoff, Jens Thomas Siveke, Ulrich Bernd Keller, Ulf Landmesser, Tienush Rassaf, Markus S Anker, Matthias Totzeck
ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity. Cancers 13 (6) (2021)
Richard Ian Lewis, H Carlo Maurer, Nikita Singh, Irene Gonzalez-Menendez, Matthias Wirth, Markus Schick, Le Zhang, Konstandina Isaakidis, Anna Katharina Scherger, Veronika Schulze, Junyan Lu, Thorsten Zenz, Katja Steiger, Roland Rad, Leticia Quintanilla-Martinez, Marion Espeli, Karl Balabanian, Ulrich Bernd Keller, Stefan Habringer
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness. Leukemia 35 (10) (2021)
Richard Lewis, Stefan Habringer, Malte Kircher, Maike Hefter, Caroline Anna Peuker, Rudolf Werner, Valëza Ademaj-Kospiri, Alexander Gäble, Wolfgang Weber, Hans-Jürgen Wester, Andreas Buck, Peter Herhaus, Constantin Lapa, Ulrich Bernd Keller
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients. EJNMMI research 11 (1) (2021)
Annemarie Albrecht, Jan Porthun, Jan Eucker, Andrew J S Coats, Stephan von Haehling, Antonio Pezzutto, Mahir Karakas, Hanno Riess, Ulrich Bernd Keller, Ulf Landmesser, Wilhelm Haverkamp, Stefan D Anker, Markus S Anker
Spontaneous Non-Sustained Ventricular Tachycardia and Premature Ventricular Contractions and Their Prognostic Relevance in Patients with Cancer in Routine Care. Cancers 13 (10) (2021)
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja C Weisel, Christof Scheid, Ulrich Bernd Keller, Dirk Hose, Florian Bassermann
MCT1 is a Predictive Marker for Lenalidomide Maintenance Therapy in Multiple Myeloma. Blood advances (2021)
Norbert Schmitz, Lorenz Trümper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron, Arnaud Jaccard, Peter Reimer, Eva Wagner, Martin Wilhelm, Laurence Sanhes, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Murielle Roussel, Frank Kroschinsky, Walter Lindemann, Peter Dreger, Andreas Viardot, Noël Milpied, Christian Gisselbrecht, Gerald Wulf, Emmanuel Gyan, Philippe Gaulard, Jacques Olivier Bay, Bertram Glass, Viola Poeschel, Gandhi Laurent Damaj, David Sibon, Alain Jacques Delmer, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Bernd Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. Blood 137 (19) (2021)
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Bernd Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas. Blood advances 5 (13) (2021)
Yingfen Hong, Nikita Singh, Stefanos Bamopoulos, Enio Gjerga, Laura K Schmalbrock, Karl Balabanian, Markus Schick, Ulrich Bernd Keller, Matthias Wirth
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System. Biomedicines 8 (12) (2020)
Alexander Biederstädt, Ulrich Bernd Keller, Christian Schneeweis, Markus Schick, Lara Schneider, Alexander Muckenhuber, Yingfen Hong, Gerrit Siegers, Lisa Nilsson, Matthias Wirth, Zahra Dantes, Katja Steiger, Kathrin Schunck, Steve Langston, H-P Lenhof, Andrea Coluccio, Felix Orben, Jolanta Slawska, Anna Scherger, Dieter Saur, Stefan Müller, Roland Rad, Wilko Weichert, Jonas Nilsson, Maximilian Reichert, Günter Schneider
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Gut 69 (8) (2020)
Matthias Wirth, Markus Schick, Ulrich Bernd Keller, Jan Krönke
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy. Cancers 12 (12) (2020)
Markus Schick, Stefan Habringer, Jonas A Nilsson, Ulrich Bernd Keller
Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers. British journal of haematology 179 (5) (2017)
Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Marita Ziepert, M Loeffler, Matthias Hänel, Judith Dierlamm, Ulrich Bernd Keller, Martin Dreyling, Lorenz Truemper, Norbert Frickhofen, Ali-Nuri Hünerlitürkoglu, Norbert Schmitz, Viola Pöschel, Tanja Rixecker, Christian Berdel, Christian Rübe, Gerhard Held, Carsten Zwick
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients. British journal of haematology 179 (3) (2017)

Ulrich Bernd Keller.css-eqlu8i{font-size:small;padding-left:4px;} (Zonera Hassan, Ulrich Keller)

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrich Bernd Keller (Zonera Hassan, Ulrich Keller)